ALNY
Alnylam Pharmaceuticals, Inc.
$268.74
$35.88B
Price
$268.74
Market Cap
$35.88B
Revenue CAGR (5Y)
+56.9%
EPS CAGR (5Y)
+5.0%
Revenue Growth
Year over Year+14.8%
2016
+90.7%
2017
-16.7%
2018
+193.4%
2019
+124.3%
2020
+71.3%
2021
+22.9%
2022
+76.2%
2023
+23.0%
2024
+65.2%
2025
EPS Growth
Year over Year-38.8%
2016
-13.2%
2017
-39.7%
2018
-7.1%
2019
+8.0%
2020
+3.5%
2021
-29.2%
2022
+62.2%
2023
+38.1%
2024
+209.6%
2025